News

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central ...
Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian cancer.
New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central ...
Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or ...
The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...
Senti Biosciences, Inc.’s SNTI share price has dipped by 6.26%, which has investors questioning if this is right time to buy.
A global study suggests that using small molecule inhibitors followed by epigenetic modifiers may significantly improve ...
How nature sounds like ocean waves and birdsong strengthen your immune system by reducing stress and boosting sleep quality.
Arovella Therapeutics (ASX:ALA) managing director and CEO Dr Michael Baker joins host Tylah Tully to to explore these ...
A novel off-the-shelf CAR NK therapy using logic gates has shown complete remissions in relapsed AML patients, according to ...
The immune system is comprised of two separate active arms of immunity to provide robust protection against disease. The two separate systems of immunity i | Immunology ...